Monday, March 17, 2025
Home 2020 October

Monthly Archives: October 2020

Hapbee, Biotech Stock Review
All News

Hapbee Technologies (HAPB): Updates and News Archive.

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Hapbee (HAPB) Soars 136% the First Day of Trading!

Editor / Curator -
Hapbee, Biotech Stock Review
Accelerator

Telehealth App Hapbee (HAPB) Goes Public and More.

Editor / Curator -
Hapbee,
All News

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

Editor / Curator -
Dalarada Health, Biotech Stock Review
All News

Dalrada Cervical Cancer Testing Kit Study.

Editor / Curator -
biotech stock review
All News

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’...

Editor / Curator -
Issam Radd
2020 Watch List

Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

Editor / Curator -
Biosig
Biotech News

Adding BioSig (BSMG) $2.95 to Watch List.

Editor / Curator -
Hepion, Biotech Stock Review
CoronaVirus

Hepion Pharma (HEPA): News Archive

Editor / Curator -
roland rick perry
Biotech News

Can This Diabetes Drug Make you Smarter?

Editor / Curator -
123Page 1 of 3

Latest article

Zomedica (ZOMDF) Surges 40% Higher, Friday.

Uncategorized Editor / Curator -
Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

And We Have a Trading Idea!

2025 Watch List Editor / Curator -
Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

2025 Watch List Editor / Curator -
GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.